Transplant Research and Risk Management
Open access peer-reviewed scientific and medical journals.
Dove Medical Press is now a member of the Open Access Initiative
An Author's Guide
A guide to help authors get their paper published.
Support Open Access and Dove Press
Promotional Article Monitoring - further details
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Managing hepatitis C in liver transplant patients with recurrent infection
(5666) Total Article Views
Authors: Tim Zimmermann, Gerd Otto, Marcus Schuchmann
Published Date September 2009
Volume 2009:1(Default) Pages 1 - 14
Tim Zimmermann1, Gerd Otto2, Marcus Schuchmann1
1Department of Internal Medicine, 2Transplantation Surgery, University of Mainz, Germany
Abstract: Hepatitis C virus (HCV) reinfection after liver transplantation (LT) and recurrent hepatitis C often lead to recurrent cirrhosis (RC). RC is one of the most frequent complications resulting in organ failure and early death after LT in HCV-positive patients with reported 5-year rates from 20% to 40%. As HCV-cirrhosis is one of the leading indications for LT, the therapeutic management is a central issue. To date, the best available therapy is a combination of pegylated interferon + ribavirin in patients with established recurrent hepatitis C proven by liver biopsy. Although increasing experience in using interferon therapy after LT has suggested better response rates, treatment is limited by a poor tolerability and high rates of severe side effects, necessitating lower doses or withdrawal of therapy. The extent to which dose reductions and the concomitant administration of growth factors affect virological response or prevent complications is still to be determined. Prospective clinical trials are mandatory to identify the best time point and schedule of antiviral treatment in transplant patients. Currently, therapeutic options need to be discussed for each individual patient. Therefore therapy should be carried out only in transplant centers with experience in managing hepatitis C after LT.
Keywords: hepatitis C, liver transplantation, recurrent infection, treatment
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
"You do a tremendous job!!" Ruben Restrepo, University of Texas Health Science Center, San Antonio.
- Facial transplantation: a review of ethics, progress, and future targets
- Neurotransmitter testing of the urine: a comprehensive analysis
- Update on tolterodine extended-release for treatment of overactive bladder
- Distal femoral opening-wedge osteotomy for lateral compartment osteoarthritis of the knee